What is she best known for?
The fields of study she is best known for:
- Immune system
- Antibody
- Cancer
Maria Cristina Mingari mostly deals with Immunology, Interleukin 21, Receptor, Cell biology and Lymphokine-activated killer cell.
Her work carried out in the field of Immunology brings together such families of science as Natural killer cell, Cytotoxic T cell and Cancer research.
Maria Cristina Mingari interconnects Natural killer T cell, Interleukin 12, Transplantation and Antigen-presenting cell in the investigation of issues within Interleukin 21.
Her Receptor study incorporates themes from Molecular biology, Natural Cytotoxicity Triggering Receptor 1, Human leukocyte antigen, Antibody and Major histocompatibility complex.
Her Cell biology research is multidisciplinary, incorporating elements of NKG2D, Cell culture and CD49b.
Her studies deal with areas such as NK-92, NK Cell Lectin-Like Receptor Subfamily D and Stromal cell as well as Lymphokine-activated killer cell.
Her most cited work include:
- Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis (1532 citations)
- Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation (828 citations)
- Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. (795 citations)
What are the main themes of her work throughout her whole career to date?
Maria Cristina Mingari focuses on Immunology, Interleukin 21, Cell biology, Receptor and Molecular biology.
Her Immunology research incorporates elements of Natural killer cell and Cytotoxic T cell.
Her Interleukin 21 research is multidisciplinary, incorporating perspectives in Innate immune system, Interleukin 12 and Antigen-presenting cell.
Her studies in Cell biology integrate themes in fields like NKG2D, Major histocompatibility complex and Innate lymphoid cell.
The study incorporates disciplines such as In vitro, Cytotoxicity, Inhibitory postsynaptic potential and Function in addition to Receptor.
Her Molecular biology research is multidisciplinary, relying on both Antigen, Antibody, Monoclonal antibody, Interleukin 2 and CD3.
She most often published in these fields:
- Immunology (51.08%)
- Interleukin 21 (30.03%)
- Cell biology (28.17%)
What were the highlights of her more recent work (between 2011-2021)?
- Immunology (51.08%)
- Cancer research (15.17%)
- Cell biology (28.17%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Immunology, Cancer research, Cell biology, Immune system and Innate lymphoid cell.
Her research in Interleukin 21 and Innate immune system are components of Immunology.
Her study looks at the intersection of Interleukin 21 and topics like Interleukin 12 with Tumor necrosis factor alpha.
Her studies deal with areas such as Chemokine, Receptor and Natural killer T cell, T cell as well as Cell biology.
Her work carried out in the field of Receptor brings together such families of science as NKG2D, Human leukocyte antigen, Inhibitory postsynaptic potential and Signal transduction.
Her Human leukocyte antigen research includes elements of Natural killer cell and CD8.
Between 2011 and 2021, her most popular works were:
- Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity (203 citations)
- Effect of tumor cells and tumor microenvironment on NK-cell function (196 citations)
- NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. (125 citations)
In her most recent research, the most cited papers focused on:
- Immune system
- Cancer
- Antibody
Maria Cristina Mingari mainly investigates Immunology, Cell biology, Interleukin 21, Interleukin 12 and Immune system.
Her Immunology research integrates issues from Cancer research and Stromal cell.
Her Cell biology study combines topics in areas such as Natural killer T cell, Chemokine and Cell type.
Maria Cristina Mingari is interested in NK-92, which is a field of Interleukin 21.
She studies Interleukin 12, focusing on Lymphokine-activated killer cell in particular.
She has researched Immune system in several fields, including Receptor, Killer-cell immunoglobulin-like receptor and Antigen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
